Intracoronary radiation with a P-32 source wire HERZ Lee, D. P., Lo, S., Forster, K. M., Tate, D. J., Raizner, A., Oesterle, S. N. 1998; 23 (6): 362-365


The Proliferation REduction with Vascular ENergy Trial (PREVENT) is a prospective randomized study of the safety and efficacy of intracoronary brachytherapy to reduce restenosis. A beta-emitter, 32P, is embedded on a wire tip and delivered to the target site through a centering catheter immediately following a coronary intervention. The radiation doses are 16, 20, and 24 Gy measured at 1 mm within the vessel wall. Follow-up includes an angiogram and IVUS at 6 months. Phase I of this trial has been completed with results expected in early 1999.

View details for Web of Science ID 000076260300005

View details for PubMedID 9816522